CDC25B; | |
BLM; TDP1; RECQL; ALOX15; HSD17B10; IDO1; BRCA1; APEX1; | |
MAPK1; | |
KDM4E; | |
CASP7; | |
TP53; | |
SLCO1B3; SLCO1B1; |
Cytochrome P450 Enzymes: |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cysteine protease | CASP7 | Caspase-7 | P55210 | CHEMBL3468 |
Enzyme_unclassified | BLM | Bloom syndrome protein | P54132 | CHEMBL1293237 |
Enzyme_unclassified | TDP1 | Tyrosyl-DNA phosphodiesterase 1 | Q9NUW8 | CHEMBL1075138 |
Enzyme_unclassified | RECQL | ATP-dependent DNA helicase Q1 | P46063 | CHEMBL1293236 |
Enzyme_unclassified | ALOX15 | Arachidonate 15-lipoxygenase | P16050 | CHEMBL2903 |
Enzyme_unclassified | HSD17B10 | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Q99714 | CHEMBL4159 |
Enzyme_unclassified | IDO1 | Indoleamine 2,3-dioxygenase | P14902 | CHEMBL4685 |
Enzyme_unclassified | BRCA1 | Breast cancer type 1 susceptibility protein | P38398 | CHEMBL5990 |
Enzyme_unclassified | APEX1 | DNA-(apurinic or apyrimidinic site) lyase | P27695 | CHEMBL5619 |
Lysine demethylase | KDM4E | Lysine-specific demethylase 4D-like | B2RXH2 | CHEMBL1293226 |
Protein Kinase | MAPK1 | MAP kinase ERK2 | P28482 | CHEMBL4040 |
Protein Phosphatase | CDC25B | Dual specificity phosphatase Cdc25B | P30305 | CHEMBL4804 |
SLC superfamily of solute carriers | SLCO1B3 | Solute carrier organic anion transporter family member 1B3 | Q9NPD5 | CHEMBL1743121 |
SLC superfamily of solute carriers | SLCO1B1 | Solute carrier organic anion transporter family member 1B1 | Q9Y6L6 | CHEMBL1697668 |
Transcription Factor | TP53 | Cellular tumor antigen p53 | P04637 | CHEMBL4096 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0009987; cellular process | GO:0000733; DNA strand renaturation | 3.174E-08 | 6.910E-04 | BLM, RECQL, TP53 |
MF | GO:0005488; binding | GO:0003684; damaged DNA binding | 1.753E-07 | 1.909E-03 | APEX1, BLM, BRCA1, TP53 |
BP | GO:0050896; response to stimulus | GO:0071417; cellular response to organonitrogen compound | 3.015E-07 | 2.115E-03 | APEX1, BLM, BRCA1, CASP7, MAPK1, TP53 |
BP | GO:0009987; cellular process | GO:0035690; cellular response to drug | 1.705E-06 | 5.305E-03 | APEX1, BLM, BRCA1, MAPK1, TP53 |
BP | GO:0009987; cellular process | GO:0071407; cellular response to organic cyclic compound | 4.978E-06 | 1.286E-02 | APEX1, BLM, BRCA1, CASP7, MAPK1 |
MF | GO:0003824; catalytic activity | GO:0009378; four-way junction helicase activity | 5.621E-06 | 1.286E-02 | BLM, RECQL |
MF | GO:0003824; catalytic activity | GO:0043140; ATP-dependent 3'-5' DNA helicase activity | 1.179E-05 | 1.677E-02 | BLM, RECQL |
MF | GO:0005488; binding | GO:0036310; annealing helicase activity | 1.572E-05 | 1.677E-02 | BLM, RECQL |
BP | GO:0009987; cellular process | GO:1902749; regulation of cell cycle G2/M phase transition | 1.885E-05 | 1.786E-02 | BLM, BRCA1, CDC25B, TP53 |
MF | GO:0003824; catalytic activity | GO:0051213; dioxygenase activity | 4.274E-05 | 2.915E-02 | ALOX15, IDO1, KDM4E |
CC | GO:0043226; organelle | GO:0000800; lateral element | 6.712E-05 | 3.654E-02 | BLM, BRCA1 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09160 Human Diseases | 09161 Cancers | hsa05206 | MicroRNAs in cancer | 5.717E-05 | 6.403E-03 | MAPK1, BRCA1, TP53, CDC25B |
09140 Cellular Processes | 09143 Cell growth and death | hsa04210 | Apoptosis | 1.436E-04 | 6.886E-03 | CASP7, MAPK1, TP53 |
09160 Human Diseases | 09163 Neurodegenerative diseases | hsa05010 | Alzheimer's disease | 2.459E-04 | 6.886E-03 | CASP7, MAPK1, HSD17B10 |
09160 Human Diseases | 09161 Cancers | hsa05216 | Thyroid cancer | 2.107E-04 | 6.886E-03 | MAPK1, TP53 |
09160 Human Diseases | 09161 Cancers | hsa05219 | Bladder cancer | 4.233E-04 | 9.300E-03 | MAPK1, TP53 |
09160 Human Diseases | 09161 Cancers | hsa05213 | Endometrial cancer | 6.813E-04 | 9.300E-03 | MAPK1, TP53 |
09160 Human Diseases | 09161 Cancers | hsa05223 | Non-small cell lung cancer | 7.898E-04 | 9.300E-03 | MAPK1, TP53 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04010 | MAPK signaling pathway | 8.321E-04 | 9.300E-03 | MAPK1, TP53, CDC25B |
09160 Human Diseases | 09161 Cancers | hsa05214 | Glioma | 1.063E-03 | 9.300E-03 | MAPK1, TP53 |
09160 Human Diseases | 09161 Cancers | hsa05210 | Colorectal cancer | 9.673E-04 | 9.300E-03 | MAPK1, TP53 |
09120 Genetic Information Processing | 09124 Replication and repair | hsa03460 | Fanconi anemia pathway | 7.077E-04 | 9.300E-03 | BLM, BRCA1 |
09160 Human Diseases | 09161 Cancers | hsa05212 | Pancreatic cancer | 1.095E-03 | 9.300E-03 | MAPK1, TP53 |
09160 Human Diseases | 09161 Cancers | hsa05230 | Central carbon metabolism in cancer | 1.129E-03 | 9.300E-03 | MAPK1, TP53 |
09160 Human Diseases | 09161 Cancers | hsa05218 | Melanoma | 1.266E-03 | 9.300E-03 | MAPK1, TP53 |
09160 Human Diseases | 09161 Cancers | hsa05220 | Chronic myeloid leukemia | 1.338E-03 | 9.300E-03 | MAPK1, TP53 |
09150 Organismal Systems | 09154 Digestive system | hsa04976 | Bile secretion | 1.266E-03 | 9.300E-03 | SLCO1B1, SLCO1B3 |
09160 Human Diseases | 09167 Infectious diseases | hsa05133 | Pertussis | 1.412E-03 | 9.300E-03 | CASP7, MAPK1 |